6417:TSESankyo Co., Ltd. Analysis
Data as of 2026-03-14 - not real-time
NT$106.50
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Securitag Assembly Group trades at TWD 106.5, just shy of its 20‑day SMA of 107.2 and 50‑day SMA of 107.93, indicating a slight pull‑back from short‑term averages. The RSI sits at 48, suggesting neutral momentum, while the MACD line remains negative with a bearish signal, and volume has been trending down, all pointing to limited upside in the near term.
Fundamentally the company posts a 6.2% revenue growth, solid gross (31%) and operating margins (16.5%), and a respectable ROE of 12%, yet its price‑to‑earnings ratio of 22 is well below the industry average of 33.7, offering relative value. However, the DCF‑derived fair value of roughly TWD 89.6 is markedly lower than the current price, highlighting a potential overvaluation gap. The dividend yield of 2.07% with a 45% payout ratio appears sustainable given positive operating and free cash flow, and the low beta of 0.59 suggests limited market‑wide volatility, though 30‑day price swings of ~28% signal notable short‑term risk.
Fundamentally the company posts a 6.2% revenue growth, solid gross (31%) and operating margins (16.5%), and a respectable ROE of 12%, yet its price‑to‑earnings ratio of 22 is well below the industry average of 33.7, offering relative value. However, the DCF‑derived fair value of roughly TWD 89.6 is markedly lower than the current price, highlighting a potential overvaluation gap. The dividend yield of 2.07% with a 45% payout ratio appears sustainable given positive operating and free cash flow, and the low beta of 0.59 suggests limited market‑wide volatility, though 30‑day price swings of ~28% signal notable short‑term risk.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Bearish MACD and negative histogram signal weakening momentum
- Current price sits below short‑term SMAs, indicating a potential pull‑back
- Decreasing trading volume reduces short‑term liquidity
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Steady earnings growth of 6% and solid profit margins
- Attractive dividend yield with a sustainable payout ratio
- Low beta (0.59) limits exposure to broader market swings
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Current price exceeds DCF fair value, suggesting upside potential if re‑rated
- Consistent cash generation supports dividend sustainability
- Valuation multiples are modest relative to industry peers, offering value
Key Metrics & Analysis
Financial Health
Revenue Growth6.20%
Profit Margin12.69%
P/E Ratio22.1
ROE12.25%
ROA5.70%
Debt/Equity40.06
P/B Ratio2.6
Op. Cash FlowNT$304.8M
Free Cash FlowNT$209.3M
Industry P/E33.7
Technical Analysis
TrendNeutral
RSI48.0
SupportNT$100.50
ResistanceNT$112.00
MA 20NT$107.20
MA 50NT$107.93
MA 200NT$101.27
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88
Valuation
Fair ValueNT$89.60
GradeOvervalued
TypeBlend
Dividend Yield2.07%
Risk Assessment
Beta0.59
Volatility27.75%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.